1. Kannan, Kalpana, Coarfa, Cristian, Chao, Pei-Wen, Matzuk, Martin M, Yen, Laising. 2015. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma. In Proceedings of the National Academy of Sciences of the United States of America, 112, E1272-7. doi:10.1073/pnas.1501735112. https://pubmed.ncbi.nlm.nih.gov/25733895/
2. Liu, Min, Liao, Lingyun, Gao, Yijie, Gao, Linbo, Zhou, Rong. 2022. BCAM Deficiency May Contribute to Preeclampsia by Suppressing the PIK3R6/p-STAT3 Signaling. In Hypertension (Dallas, Tex. : 1979), 79, 2830-2842. doi:10.1161/HYPERTENSIONAHA.122.20085. https://pubmed.ncbi.nlm.nih.gov/36252138/
3. Akiyama, Hirotada, Iwahana, Yoshimasa, Suda, Mikiya, Komiya, Yuko, Tashiro, Fumio. 2013. The FBI1/Akirin2 target gene, BCAM, acts as a suppressive oncogene. In PloS one, 8, e78716. doi:10.1371/journal.pone.0078716. https://pubmed.ncbi.nlm.nih.gov/24223164/
4. Huang, Guangzhao, Chen, Su, He, Jialu, Guo, Zhiyong, Li, Chunjie. 2024. Histone Lysine Lactylation (Kla)-induced BCAM Promotes OSCC Progression and Cis-Platinum Resistance. In Oral diseases, , . doi:10.1111/odi.15179. https://pubmed.ncbi.nlm.nih.gov/39503345/
5. Jin, Juan, Xie, Shanshan, Sun, Qiang, Zhuo, Wei, Zhou, Tianhua. 2020. Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis. In Molecular oncology, 14, 829-845. doi:10.1002/1878-0261.12638. https://pubmed.ncbi.nlm.nih.gov/31951095/
6. Latini, Flavia Roche Moreira, Bastos, André Uchimura, Arnoni, Carine Prisco, Castilho, Lilian, Cerutti, Janete Maria. 2012. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. In Blood cells, molecules & diseases, 50, 161-5. doi:10.1016/j.bcmd.2012.10.009. https://pubmed.ncbi.nlm.nih.gov/23168236/
智鼠故事 
